Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Sep 22, 2020
Nearly 30 representatives encourage House leaders to modify in the next COVID-19 response package impending thresholds for qualifying participants in Advanced Alternative Payment Models, which they said threaten to “derail” the movement to value-based care under the Medicare Access and CHIP Reauthorization Act.
AHA Comments Submitted In Response to HRSA’s RFI on Health Professional Shortage Area (HPSA) ScoringSep 18, 2020
AHA's input on the Health Resources and Services Administration’s (HRSA) Health Professional Shortage Area (HPSA) Scoring Criteria request for information (RFI).
Sep 18, 2020
The AHA requests that the Department of Health and Human Services revise certain FAQs that place problematic restrictions on the use of some CARES Act Provider Relief Fund dollars.
AHA Comments on NASEM’s Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 VaccineSep 8, 2020
AHA comments on the National Academies of Sciences, Engineering and Medicine’s Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine.
Sep 8, 2020
AHA to HHS again expressing concern with recent actions taken by several major drug manufacturers to limit the distribution of certain 340B drugs to our hospital members.
Sep 4, 2020
AHA urges the Centers for Medicare & Medicaid Services (CMS) to withdraw the condition of participation that hospitals report daily COVID-19 data.
Aug 31, 2020
Letter from AHA to President Donald Trump urging additional support for rural hospitals and health systems.
Aug 27, 2020
On behalf of the nation’s 340B hospitals, AHA, others urge HHS to protect vulnerable communities from actions taken by five of the nation’s largest pharmaceutical manufacturers that undermine access to critical drugs and other health care services.
Aug 26, 2020
AHA urges the Centers for Medicare & Medicaid Services to provide additional flexibility regarding the agency’s new COVID-19 test documentation requirement for the diagnostic-related group (DRG) add-on payment.
Aug 24, 2020
AHA comments on the Centers for Medicare & Medicaid Services’ calendar year 2021 proposed rule for the Home Health prospective payment system (PPS).